Sorry, you need to enable JavaScript to visit this website.
Skip to content

////// Science for a better life

  • Global
  • Media/Press
  • Report a Side Effect
  • Contact
  • English
Home
Pharmaceuticals
  • Living with a Disease
    Living with a Disease
    Living with a Disease

    Quality of life is a mutual responsibility for all of us.

    • Overview
    • Cancer
      • TRK Fusion Cancer
      • Gastrointestinal Stromal Tumor
      • Liver Cancer
      • Prostate Cancer
      • Kidney Cancer
      • Breast Cancer
      • Thyroid Cancer
      • Virtual Press Room
        • HCC Virtual Media Briefing
        • ESMO Global Educational Webinar
    • Cardiovascular & Kidney Diseases
      • Thrombosis
      • Heart Attack
      • Chronic Kidney Disease
      • Heart Failure
      • High Blood Pressure
      • Stroke & Atrial Fibrillation
      • Diagnosing Heart Disease
    • Eye Conditions
      • Diabetic macular edema
      • Age-related Macular Degeneration
    • Hemophilia
    • Women's Healthcare
      • Contraception
      • Heavy Menstrual Bleeding
      • Menopausal Complaints
      • Endometriosis
      • Uterine Fibroids
      • Acne Therapy
    • Other Diseases
      • Pulmonary Hypertension
  • Innovation
    Innovation
    Innovation

    For over 120 years, Bayer has been researching and developing innovative medications and new therapeutic approaches that help make a difference to people’s lives.

    • Overview
    • Technologies
      • RNA interference
      • High-throughput screening
      • Digitalization in drug discovery
      • PROTACs
      • Diagnostic imaging
    • Trends
      • AAV Therapeutics
      • Cell Therapy - Stem Cells
      • Pharmacogenetics
      • Targeted-thorium Conjugates
      • Precision medicine
      • Biomarkers
      • AI in Pharma
    • Development Pipeline
      • Pipeline Insights
    • Clinical Trials
      • Ethics in Clinical Trials
      • FAQ
      • Transparenz-Richtlinie
      • Zugang zu Medikamenten
  • Partnering
    Partnering
    Partnering

    Bayer is a reliable and flexible partner who can help you take your work to the next stage and make the most out of its potential.

    • Overview
    • Why we Partner
    • Areas of Interest
    • Partnering With us
      • Forms of Collaboration
      • Chemical Probes for Open Access
    • Blog Partnering Insights
    • Where to Meet us
  • Who we are
    Who we are
    Who we are

    We are committed to the principles of sustainable development. With our products we aim to improve people's quality of life.

    • Overview
    • Our Engagement
      • Patient organization
      • Patient Engagement
      • #WeWontRest
      • Tropical Diseases
      • Family Planning
      • Healthy Aging
    • Global Health Policy
    • Newsletter
English
German
Mobile Navigation

Breadcrumb

  1. Home
  2. Search

Error message

English
German

Pagination

  • Previous page Previous
  • Page 3 /
  • Current page 4 /
  • Page 5 /
  • Page 6
  • Next page Next
31 - 40 of about 189 Documents
Data Privacy Statement / Imprint
Data Privacy Statement / Imprint
https://pharma.bayer.com/global-twitter-channel-bayerpharma-bayer-pharmaceuticals
oncology_1
Oncology Treatment’s Next Frontier: Precision Medicine
At the ASCO 2019 congress, the annual meeting of the American Society of Clinical Oncology, I had the opportunity to connect in various meetings and discussions with the Oncology Community.
https://pharma.bayer.com/oncology-treatments-next-frontier-precision-medicine
When patients become our experts
When patients become our experts
https://pharma.bayer.com/when-patients-become-our-experts
Artificial Intelligence
Can AI Improve Cardiovascular Disease Outcomes?
Artificial intelligence will help drive unprecedented productivity improvements and better outcomes across the value chain from drug discovery to delivery.
https://pharma.bayer.com/can-ai-improve-cardiovascular-disease-outcomes
Genomic Testing
First Treatment For TRK Fusion Cancer Approved
The United States Food and Drug Administration (U.S. FDA) has approved a new treatment option for children and adults suffering from TRK fusion cancer.
https://pharma.bayer.com/first-treatment-trk-fusion-cancer-approved
healthy aging
Healthy Heart for Healthy Aging – Download the report
Life expectancy is increasing and there is an acceleration of global population aging. The global health community must take action to proactively address age-related diseases.
https://pharma.bayer.com/healthy-heart-healthy-aging-download-report
Immun_sys1
How the immune system fights cancer
The evolution of immuno-oncology (IO) represents a major advancement in cancer therapy over the past decade. Across all different tumors around 70 percent of patients who receive IO treatments do not benefit from them.
https://pharma.bayer.com/how-immune-system-fights-cancer
heart_blood_1
What You Might Not Know About Scans
If your doctor suspects that you have a problem with your heart or blood, the next step could be to have a scan with a radiologist.
https://pharma.bayer.com/what-you-might-not-know-about-scans
ab
abc
https://pharma.bayer.com/title-section-page
River blindness
River Blindness
Onchocerciasis is an infection caused by the parasitic worm spread by the bite of an infected blackfly, mostly found in rural agricultural areas in sub-Saharan Africa.
https://pharma.bayer.com/river-blindness

Pagination

  • Previous page Previous
  • Page 3 /
  • Current page 4 /
  • Page 5 /
  • Page 6
  • Next page Next
31 - 40 of about 189 Documents
  • Living With a Disease
    • Cancer
    • Cardiovascular & Kidney Diseases
    • Eye Conditions
    • Hemophilia
    • Other Diseases
  • Innovation
    • Technologies
    • Trends
    • Development Pipeline
    • Clinical Trials
  • Partnering
    • Why we Partner
    • Areas Of Interest
    • Partnering With us
    • Where to Meet us
  • Who we are
    • Our Engagement
    • Global Health Policy
Get in Touch
Do you have any queries or comments about our website, our products or any of our services?
Contact Us
Report A Side Effect

Follow Us

Copyright © Bayer AG

  • Conditions of use
  • Privacy statement
  • Imprint